Phenotype and clinics | SSPS is characterized by eyelid cysts (apocrine hidrocystomas), palmoplantar keratoderma, hypodontia, hyperhidrosis, hypotrichosis and onychodystrophy, as well as other, often variable, ectodermal developmental anomalies (Schöpf et al., 1971; Monk et al., 1992). SSPS shows clinical overlap with odonto-onycho-dermal dysplasia (OODD), but the eyelid cysts are a typical sign of SSPS. Some features may not present until adulthood and diagnosis can be delayed (Granger et al., 2012). The presence of ectodermal abnormalities in some carriers can lead to confusion in the mode of inheritance (Craigen et al., 1997). |
|  |
| |
| Eyelid cysts (apocrine hidrocystomas) that can also extend to the peri-ocular regions and nasal bridge. |
| |
Neoplastic risk | The neoplastic risk in SSPS is controversial. Some authors consider that SSPS can be associated with an increased risk of benign as well as malignant skin tumours (Monk et al., 1992). Reports include an increased incidence of benign adnexal tumours, such as eyelid hidrocystomas or eccrine syringofibroadenomas (Starink, 1997), and possibly a higher risk of malignant skin tumours such as squamous cell carcinoma, basal cell carcinoma and eccrine porocarcinoma (Bohring et al., 2009; Monk et al., 1992; Starink, 1997). |
Treatment | There is no effective treatment for SSPS. Hyperhidrosis of the palms may respond partially to tap water iontophoresis (although use of anti-cholinergics may induce excessive systemic side-effects such as dry mouth, dizziness and drowsiness). Systemic retinoids can exacerbate skin peeling, although low doses may help some individuals. The apocrine hidrocystomas can be improved by electrocautery. Regular skin examination to detect non-melanoma skin cancer may be advisable. Regular dental care/surgery is indicated in most cases. Hair/nail cosmesis may help some individuals. Psychological support should be offered, as necessary. |
Evolution | Many of the features of ectodermal dysplasia only manifest or worsen during adulthood. In some individuals with SSPS, the apocrine hidrocystomas tend to become larger and more numerous with age. |
Prognosis | Life expectancy is normal ; the main challenge is the symptomatic management of whichever ectodermal pathologies cause the patient the most concern. |
Mutation in WNT10A is associated with an autosomal recessive ectodermal dysplasia: the odonto-onycho-dermal dysplasia. |
Adaimy L, Chouery E, Megarbane H, Mroueh S, Delague V, Nicolas E, Belguith H, de Mazancourt P, Megarbane A. |
Am J Hum Genet. 2007 Oct;81(4):821-8. Epub 2007 Aug 9. |
PMID 17847007 |
|
WNT10A mutations are a frequent cause of a broad spectrum of ectodermal dysplasias with sex-biased manifestation pattern in heterozygotes. |
Bohring A, Stamm T, Spaich C, Haase C, Spree K, Hehr U, Hoffmann M, Ledig S, Sel S, Wieacker P, Ropke A. |
Am J Hum Genet. 2009 Jul;85(1):97-105. Epub 2009 Jun 25. |
PMID 19559398 |
|
Two families confirm Schopf-Schulz-Passarge syndrome as a discrete entity within the WNT10A phenotypic spectrum. |
Castori M, Castiglia D, Brancati F, Foglio M, Heath S, Floriddia G, Madonna S, Fischer J, Zambruno G. |
Clin Genet. 2011 Jan;79(1):92-5. doi: 10.1111/j.1399-0004.2010.01513.x. |
PMID 21143469 |
|
Only four genes (EDA1, EDAR, EDARADD, and WNT10A) account for 90% of hypohidrotic/anhidrotic ectodermal dysplasia cases. |
Cluzeau C, Hadj-Rabia S, Jambou M, Mansour S, Guigue P, Masmoudi S, Bal E, Chassaing N, Vincent MC, Viot G, Clauss F, Maniere MC, Toupenay S, Le Merrer M, Lyonnet S, Cormier-Daire V, Amiel J, Faivre L, de Prost Y, Munnich A, Bonnefont JP, Bodemer C, Smahi A. |
Hum Mutat. 2011 Jan;32(1):70-2. |
PMID 20979233 |
|
Schopf-Schulz-Passarge syndrome with an unusual pattern of inheritance. |
Craigen WJ, Levy ML, Lewis RA. |
Am J Med Genet. 1997 Aug 8;71(2):186-8. |
PMID 9217219 |
|
Late diagnosis of ectodermal dysplasia syndrome. |
Granger RH, Marshman G, Liu L, McGrath JA. |
Australas J Dermatol. 2012 Jun 4. doi: 10.1111/j.1440-0960.2012.00895.x. [Epub ahead of print] |
PMID 22670871 |
|
The Wnt signaling pathway in development and disease. |
Logan CY, Nusse R. |
Annu Rev Cell Dev Biol. 2004;20:781-810. (REVIEW) |
PMID 15473860 |
|
Schopf-Schulz-Passarge syndrome. |
Monk BE, Pieris S, Soni V. |
Br J Dermatol. 1992 Jul;127(1):33-5. |
PMID 1637691 |
|
Schopf-Schulz-Passarge syndrome resulting from a homozygous nonsense mutation in WNT10A. |
Nagy N, Wedgeworth E, Hamada T, White JM, Hashimoto T, McGrath JA. |
J Dermatol Sci. 2010 Jun;58(3):220-2. Epub 2010 Mar 23. |
PMID 20418069 |
|
Schopf-Schulz-Passarge syndrome resulting from a homozygous nonsense mutation, p.Cys107X, in WNT10A. |
Petrof G, Fong K, Lai-Cheong JE, Cockayne SE, McGrath JA. |
Australas J Dermatol. 2011 Aug;52(3):224-6. doi: 10.1111/j.1440-0960.2011.00788.x. Epub 2011 Jun 29. |
PMID 21834823 |
|
Syndrome of cystic eyelids, palmo-plantar keratosis, hypodontia and hypotrichosis as a possible autosomal recessive trait. |
Schopf E, Schulz HJ, Passarge E. |
Birth Defects Orig Artic Ser. 1971 Jun;7(8):219-21. |
PMID 4281327 |
|
Eccrine syringofibroadenoma: multiple lesions representing a new cutaneous marker of the Schopf syndrome, and solitary nonhereditary tumors. |
Starink TM. |
J Am Acad Dermatol. 1997 Apr;36(4):569-76. (REVIEW) |
PMID 9092743 |
|
Phenotypic variability associated with WNT10A nonsense mutations. |
Van Geel M, Gattas M, Kesler Y, Tong P, Yan H, Tran K, Steijlen PM, Murrell DF, Van Steensel MA. |
Br J Dermatol. 2010 Jun;162(6):1403-6. doi: 10.1111/j.1365-2133.2010.09703.x. Epub 2010 Feb 15. |
PMID 20163410 |
|
Intra-familial variability of ectodermal defects associated with WNT10A mutations. |
Wedgeworth EK, Nagy N, White JM, Pembroke AC, McGrath JA. |
Acta Derm Venereol. 2011 May;91(3):346-7. |
PMID 21279306 |
|